 and high) based
on projected beneﬁt from anatomic revascularizationd
from no (or very low) beneﬁt to greatest potential beneﬁt.
In this process, certain presentations at the extremes of
amputation risk (eg, rest pain alone vs extensive infection
without ischemia) are classiﬁed quite differently than in
the disease staging system above (Table IV, a) that focused
on amputation risk. Table IV, b is quite informative for